Chief Financial Officer | Leadership, Strategic Planning, Medical Device
CurrentMid-market, private equity / family office owned manufacturer and distributor of drug delivery medical devices in the consumer retail, medical / surgical and veterinary markets.Part of the core leadership group responsible for accelerating sales and earnings growth following sale of the business to a family office in 2014, and a private equity fund in 2020.STRATEGIC and OPERATING PLANNING- Designed and implemented core business planning processes and reporting to better connect the Company’s strategic vision to plan initiatives and investments.TREASURY- Secured financing through JPMorgan Chase & Co, providing the Company’s ownership group greater flexibility in managing the Company’s capitalization structure.PROCESS / PROFITABILITY IMPROVEMENTS- Implemented new product costing structures designed to provide better visibility into the Company’s operating results and allow for simplified product sourcing decisions between production facilities in South Dakota and South Korea.- Leading expanded usage of the Company’s information technology systems (NAV ERP system, ADP HRIS / payroll systems) designed to improve visibility to Company performance, drive productivity gains, and establish a foundation to support growth.- Led market evaluation of the Company’s compensation and benefits offerings. Implemented various enhancements to provide a more competitive package and reduce direct labor turnover.